Researchers conducted a model-based economic evaluation to find the cost-effective healthcare intervention for lowering C. diff rates. They synthesized efficacy evidence from research literature and used it to inform the effectiveness of both bundled approaches and stand-alone interventions for C. diff.
Researchers found a bundled approach of improving hand hygiene and environmental cleaning results is the best combination of increased health benefits and cost-savings related to C. diff treatment. The bundled approach has the highest mean net monetary benefit when compared to all other interventions.
“These findings provide healthcare decision-makers with novel information about the allocation of scarce resources relating to Clostridium difficile,” study authors concluded.
More articles on clinical leadership and infection control:
Hospital Quality Institute CEO: The facts about Stanford’s patient safety record
How Children’s National Health System is doubling safety event reports through quality initiative
Leapfrog: Hawaii No. 1 state with highest proportion of “A”-grade hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
